1ST Source Bank Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

1ST Source Bank trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,597 shares of the healthcare conglomerate’s stock after selling 84 shares during the period. 1ST Source Bank’s holdings in UnitedHealth Group were worth $813,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after buying an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in UnitedHealth Group by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the period. Capital Research Global Investors raised its stake in shares of UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after buying an additional 324,733 shares during the last quarter. Capital International Investors boosted its stake in shares of UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after buying an additional 542,424 shares during the last quarter. Finally, Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $5,802,231,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.0 %

NYSE UNH opened at $594.32 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The business’s fifty day simple moving average is $569.08 and its 200-day simple moving average is $517.57. The firm has a market cap of $548.81 billion, a PE ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $6.14 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on UNH shares. Truist Financial lifted their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company lifted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, September 9th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.